CP
Cyclacel Pharmaceuticals Inc
🇺🇸XNAS.CYCCUnited StatesHealthcare
$1.05USDup +0.15 (+16.67%)OpenEnd of day5:44 PM
Price$1.05+0.15 (+16.67%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US23254L6039
- CUSIP
- 23254L603
Company
- Employees
- 0
- Headquarters
- Kuala Lumpur, United States
- Website
- https://www.cyclacel.com
Market
- Shares outstanding
- 2.2M
- Market cap
- $2.35M
Highlights
- Market cap
- $2.02M
- EPS LTM
- -$4.05
- P/E LTM
- -0.26calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- -$25K-131.25%down year on year
- Net income
- -$6.41M+63.4%up year on year
- Gross margin
- 124%+48.06%up year on year
- Free cash flow
- -$4.43M+61.55%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.